Publikationen, an denen er mitarbeitet Miguel Méndez Ureña (1)

2007

  1. First-line treatment with vinorelbine (VNR) plus carboplatin (CBDCA) for patients with advanced non-small-cell lung cancer (NSCLC): MAP4/OP18 mRNA expression as marker predictive of response

    EJC SUPPLEMENTS